Skip to content

EGID

  • About us
    • Our history
    • The project
    • The teams
    • PreciDIAB
  • Plateforms
    • LIGAN-PM
    • DiabInnov
    • EGID INNOVATION
    • Immunophénotypage
    • ADME-PK – Drug-Design
    • IMPACT PM
  • Formations
    • Master 2
    • Doctorates
    • Graduate Programme
  • News
    • Our publications
    • Events
  • Français

What is EGID?

EGID (European Genomic Institute for Diabetes) is first and foremost an international research institute focused on diabetes (type 1 and 2), obesity and the associated risk factors, the purpose of which is to disseminate and promote the “research product”.

EGID is the first diabetes research institute of international visibility based in France and the only center in the world with such a vast field of action in its field: fundamental research, university training, continuing education, prevention, prediction, clinical applications, industrial development and promotion of public health actions.

The teams

Composed of 5 research units, EGID brings together a critical mass unique in France of more than 250 employees:

  • UMR 1283/8199 “(Epi) Functional genomics and Molecular Physiology Of Diabetes and Associated Diseases”
  • UMR 1011 “Nuclear receptors, cardiovascular disease and diabetes”
  • UMR 1190 “Translational Research on Diabetes”
  • UMR 1172 “Development and Plasticity of the Neuroendocrine Brain”
  • UMR 1177 “Drugs and Molecules for Living Systems”
Learn more

Our missions

EGID is intended to play a leading role globally in the area of diabetes, obesity and associated risk factors.

The fundamental mission of the institute will be to achieve major breakthroughs both in the better understanding of these diseases and in their diagnosis and therapeutic treatments.

Nos Formations

Master 2

Master “Diabetes and cardiovascular diseases”: Track of solid knowledge on the most recent approaches, technologies and research results in the field of diabetes and cardiometabolic diseases.

Master “Precision Health” : International course open to students of scientific, medical / pharmaceutical and (bio) informatics training.

En savoir plus

Doctorates

EGID laboratories welcome students each year for the preparation of their doctoral thesis in the Lille Biology-Health Doctoral School.

Discover the list of theses in progress and theses defended over the last 5 years as well as the thesis subjects offered for mobility for the start of the 2021 academic year.

En savoir plus

Graduate programme

The “precision health” graduate programme offers a unique training in research excellence and aims to train students in innovative concepts that will guide the research and health of tomorrow.

It is open to biologists, physicians and pharmacists, as well as national and international (bio) computer scientists, to train the next generation of research leaders for academia, industry and the world of biotechnology.

En savoir plus

Our platforms

EGID has high-performance platforms for genomics, immuno-phenotyping and bio-therapy of diabetes and has put them at the service of their regional, national and European partners in order to promote collaboration.

LIGAN-PM
DiabInnov
EGID INNOVATION
Immunophénotypage
ADME-PK - Drug Design
IMPACT PM
LIGAN-PM

The Equipex LIGAN-PM platform, directed by Philippe FROGUEL, is dedicated to the sequencing of the human genome. Our latest generation high-throughput sequencers are geared towards personalized sequencing of patients with frequent diseases (such as diabetes, obesity, cardiovascular disease, cancer, Alzheimer’s disease) or rare diseases (such as monogenic forms of diabetes and obesity, and familial forms of cancer).

Internet Website : http://ligan.good.cnrs.fr/presentation/la-plateforme-ligan/

Contact : contact-good@listes.egid.fr

Read More

DiabInnov

DiabInnov is a research platform that helps companies and academic laboratories to research and develop innovative therapies for the treatment of metabolic diseases and their comorbidities, in order to significantly advance the therapeutic management of patients.

Website : https://diabinnov.eu/

Contact : contact@diabinnov.eu

Read More

EGID INNOVATION

EGID INNOVATION

The “EGID Innovation” platform is a project hotel. Located in the heart of the EGID building, it is intended to house biotechnology companies that are developing their projects in synergy with EGID. It complements the services offered by hotels with traditional projects by providing access to an exceptional scientific environment (Labex), state-of-the-art equipment and technological platforms of excellence (Equipex).

Read More

Immunophénotypage

The immuno-phenotyping platform is equipped with several state-of-the-art equipment : a sorting analyzer allowing the simultaneous purification of 6 cell populations and an analyzer by mass cytometry, a technique in full development making it possible to analyze simultaneously up to 42 markers.

Contacts :

David Dombrowicz (Team director) : david.dombrowicz@pasteur-lille.fr

Olivier Molendi-Coste (Technical manager and research engineer) : olivier.molendi-coste@inserm.fr

Laurent Pineau (Research engineer) : laurent.pineau@inserm.fr

Read More

ADME-PK - Drug Design

La caractérisation qualitative et quantitative des effets associés à l’administration d’un composé à un animal modèle est la clé de voûte du processus de découverte de médicaments. Cette étape est essentielle pour estimer un futur effet thérapeutique et évaluer le rapport risque-bénéfice d’un candidat médicament. À ce titre, elle constitue une étape nécessaire dans la plupart des projets d’innovation thérapeutique, avant de décider d’engager un candidat pour des essais cliniques.

Savoir-faire et services

https://www.deprezlab.fr/early-formulation-adme-pharmacokinetics

Contacts

Managers scientifiques : Pr. B. Déprez & Dr F. Leroux (florence.leroux@univ-lille.fr)

Manager opérationnel: C. Piveteau (catherine.piveteau@univ-lille.fr)

Lire plus

IMPACT PM

IMPACT PM

The IMPACT-PM (Integrative Metabolomics and Phenomics AnalytiCs for Translational and Precision Medicine) platform is dedicated to high-resolution mass spectrometry-based metabolomics in biomedical settings. Our mission is to deliver a comprehensive characterisation of the metabolome in various biomedical contexts using high-throughput high-resolution accurate mass workflows, with enhanced coverage and high-confidence annotation for more than two thousand metabolites, lipids and drugs.

Read More

Contacts

Group Leader and Platform Head : Dr. Marc-Emmanuel DUMAS (marc-emmanuel.dumas@cnrs.fr)
Postdoc, lead for mass spectrometry : Dr. Mickael CHEVALIER (mickael.chevalier@inserm.fr)
Postdoc, lead for chemometrics: Dr. Francesc PUIG CASTELLVÍ (francesc.puig-castellvi@inserm.fr) 
Postdoc, lead for standards library and Met ID: Dr. Romina PACHECO TAPIA (romina.pachecotapia@univ-lille.fr)
PhD student: Maxime DESLANDE (maxime.deslande@univ-lille.fr)

Diabete is a major cause of early death and disability

0
Millions

people with diabetes go undiagnosed

0
Millions

patients affected worldwide

0
Millions

people will potentially be affected by diabetes in 2030

Our dates to remember

03 April 2023

EGID seminar, Monday 03rd of April

We are very happy to invite you to an EGID seminar given by Jason Flannick and Noel Burtt from Cambridge, US This event will be held at the Pôle Recherche, […]

Find out more »
27 November 2023

EGID SYMPOSIUM 2023

The 7th EGID Symposium will take place at Lille Grand Palais, on November 27 - 28, 2023. Once again the EGID Symposium will bring together high-leveled speakers. As usual, a […]

Find out more »
Lille Grand Palais, 1, Boulevard des Cités-Unies
Euralille, 59777 France
+ Google Map

Our News

Visite du plateau de métabolome

•
October 21, 2022

Visite du plateau de métabolome Nous avons le plaisir de vous convier à la visite du plateau de métabolome qui aura lieu:-> …

Metabolic surgery: a new step towards precision medicine

•
March 31, 2022

Metabolic surgery: a new step towards precision medicine Raverdy V, Cohen RV, Caiazzo R, Verkindt H, Petry TBZ, Marciniak C, Legendre B, …

Save the Date Symposium EGID 2021

EGID Symposium 2021

•
September 10, 2021

Symposium EGID 2021 The 2021 edition of our unmissable symposium will be held on December 14, 2021 at Lille Grand Palais. On …

PhD studentship

•
August 3, 2021

PhD studentship The laboratory CNRS UMR1283/8199 “Génomique intégrative et Modélisation des Maladies Métaboliques” (Integrated genomics and metabolic diseases modelling) offers up a …

See more news
Informations

+33 (0)3 20 97 42 51

EGID, PÔLE RECHERCHE,
1 PLACE DE VERDUN
59045 LILLE CEDEX
FRANCE

Agenda
  • Contact
  • Our partners
  • Legal Notices
  • Contact
  • Our partners
  • Legal Notices
Youtube
© EGID Copyright 2021. All Rights Reserved.

Nous utilisons des cookies. Veuillez consulter notre page de politique de confidentialité pour plus d'informations.

OK
X